Marinus Pharmaceuticals | Beneficio Bruto En Ventas

Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Amgen USD 5.08B 14M 2023-12
Biogen USD 1.77B 102.7M 2023-12
Eisai JPY 140.19B 12.82B 2023-09
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Marinus Pharmaceuticals USD 6.88M 1.19M 2023-09
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
PTC Therapeutics USD 277.94M 90.85M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Supernus Pharmaceuticals USD 144.69M 10.41M 2023-12
UCB EUR 1.79B 24M 2023-06
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Marinus Pharmaceuticals Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.